Dear Colleagues,
The aim of this Special Issue is to provide a comprehensive collection of articles on new technologies and innovations for the treatment of coronary and structural heart diseases.
To this end, we invite state-of-the-art reviews and original research in this area for consideration to be included in the special issue. Examples may include innovations in interventional techniques, reviews of new devices and technologies for coronary artery disease (i.e., stent technology, atherectomy devices, coronary physiology, intracoronary imaging, and robotics), structural heart diseases (i.e., transcatheter aortic valve replacement, transcatheter edge-to edge repair, atrial septal defect, left atrial appendage closure, patent foramen ovale), and advances in the management of complex and high-risk coronary interventions (CHIP).
We look forward to receiving your submissions!
Prof. Ciro Indolfi and Dr. Alberto Polimeni
Guest Editors
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2200 USD. Submitted manuscripts should be well formatted in good English.
- Open Access Original ResearchImpacts of Left Atrial Appendage Treatments on Mitral Valve Diseases during Surgical AblationsCan Zhou, Yichen Zhao, Cheng Zhao, Qing Ye, ... Jiangang WangRev. Cardiovasc. Med. 2024, 25(1), 13; https://doi.org/10.31083/j.rcm2501013(This article belongs to the Special Issue Advances in Coronary and Structural Heart Interventions)17Downloads99Views
- Open Access Original ResearchIntermediate Hyperglycemia Increases the Risk of All-Cause Mortality in Premature Coronary Artery Disease Patients Undergoing Percutaneous Coronary InterventionZiyou Zhou, Linfang Qiao, Yihang Ling, Yibo He, ... Jiyan ChenRev. Cardiovasc. Med. 2023, 24(12), 352; https://doi.org/10.31083/j.rcm2412352(This article belongs to the Special Issue Advances in Coronary and Structural Heart Interventions)23Downloads173Views
- Open Access Systematic ReviewP2Y12 Inhibitor vs Aspirin Monotherapy Following Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: An Updated Meta-AnalysisTong Gao, Chang Meng, Yintang Wang, Siyuan Li, ... Ping ZhangRev. Cardiovasc. Med. 2023, 24(10), 284; https://doi.org/10.31083/j.rcm2410284(This article belongs to the Special Issue Advances in Coronary and Structural Heart Interventions)44Downloads163Views